NO964699D0 - Stabile, krystallinske tetrahydrofolsyresalter og fremgangsmåter for fremstilling av slike - Google Patents

Stabile, krystallinske tetrahydrofolsyresalter og fremgangsmåter for fremstilling av slike

Info

Publication number
NO964699D0
NO964699D0 NO964699A NO964699A NO964699D0 NO 964699 D0 NO964699 D0 NO 964699D0 NO 964699 A NO964699 A NO 964699A NO 964699 A NO964699 A NO 964699A NO 964699 D0 NO964699 D0 NO 964699D0
Authority
NO
Norway
Prior art keywords
processes
preparation
tetrahydrofolic acid
acid salts
stable crystalline
Prior art date
Application number
NO964699A
Other languages
English (en)
Other versions
NO964699L (no
Inventor
Hans Rudolf Muller
Martin Ulmann
Rudolf Moser
Thomas Ammann
Original Assignee
Eprova Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eprova Ag filed Critical Eprova Ag
Publication of NO964699D0 publication Critical patent/NO964699D0/no
Publication of NO964699L publication Critical patent/NO964699L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
NO964699A 1995-11-07 1996-11-06 Stabile, krystallinske tetrahydrofolinsyresalter og fremgangsmåter for fremstilling av slike NO964699L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH03145/95A CH689831A5 (de) 1995-11-07 1995-11-07 Stabile kristalline Tetrahydrofolsaeure-Salze.

Publications (2)

Publication Number Publication Date
NO964699D0 true NO964699D0 (no) 1996-11-06
NO964699L NO964699L (no) 1997-05-09

Family

ID=4249585

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964699A NO964699L (no) 1995-11-07 1996-11-06 Stabile, krystallinske tetrahydrofolinsyresalter og fremgangsmåter for fremstilling av slike

Country Status (19)

Country Link
US (1) US5817659A (no)
EP (1) EP0773221B1 (no)
JP (1) JP3382103B2 (no)
KR (2) KR100296162B1 (no)
CN (1) CN1067392C (no)
AT (1) ATE191482T1 (no)
AU (1) AU707443B2 (no)
CA (1) CA2187409C (no)
CH (1) CH689831A5 (no)
DE (1) DE59604878D1 (no)
DK (1) DK0773221T3 (no)
ES (1) ES2145360T3 (no)
GR (1) GR3033727T3 (no)
HU (1) HUP9603072A3 (no)
NO (1) NO964699L (no)
PT (1) PT773221E (no)
RU (1) RU2187508C2 (no)
TW (1) TW533214B (no)
ZA (1) ZA969284B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH693255A5 (de) * 1997-06-13 2003-05-15 Eprova Ag Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels.
AU1223400A (en) * 1998-10-22 2000-05-08 Phillip B. B. Moheno Novel pterin antineoplastic agents
CH693905A5 (de) 1999-04-15 2004-04-15 Eprova Ag Stabile kristalline Salze von 5-Methyltetrahydrofolsäure.
CH694251A5 (de) 1999-07-14 2004-10-15 Eprova Ag Herstellung von Tetrahydropterin und Derivaten.
FR2816944B1 (fr) * 2000-11-17 2005-10-21 Dospharma Nouveaux sels de lithium, les compositions pharmaceutiques a base de ces sels de lithium et leurs applications comme medicament
DE602005026352D1 (de) * 2004-09-15 2011-03-31 Nipro Corp Wässrige, stabile (6S)-Folinsäurelösung zur Injektion
US7947662B2 (en) 2008-02-20 2011-05-24 Gnosis S.P.A. Folates, compositions and uses thereof
KR101512624B1 (ko) * 2008-02-20 2015-04-16 그노시스 에스.피.에이. 폴레이트, 이의 조성물 및 용도
US9629846B1 (en) 2013-11-14 2017-04-25 Argent Development Group, Llc Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women
US9492421B1 (en) 2013-11-14 2016-11-15 Argent Development Group, Llc Nutritional supplements for treatment of iron deficiency anemia
WO2016185413A1 (en) 2015-05-20 2016-11-24 Nestec S.A. Modified release formulations
EP3609894A1 (en) 2017-03-31 2020-02-19 Merck Patent GmbH Crystalline sodium salt of 5-methyl-(6s)-tetrahydrofolic acid
WO2018178144A1 (en) 2017-03-31 2018-10-04 Merck Patent Gmbh Crystalline sodium salt of 5-methyl-(6s)-tetrahydrofolic acid
EP3461826A1 (en) 2017-09-29 2019-04-03 Aprofol AG Multifunctional folate salts
CN108976232A (zh) * 2018-09-19 2018-12-11 江苏红豆杉药业有限公司 一种四氢叶酸钙的合成方法
EP3646873A1 (en) 2018-10-31 2020-05-06 Aprofol AG Folate salts
CN109456330B (zh) * 2018-11-26 2021-05-14 连云港德洋化工有限公司 叶酸类稳定复合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124452A (en) * 1978-07-10 1992-06-23 Bioresearch S.P.A. Process for producing d,1-5-methyltetrahydrofolic acid and its salts
MX169933B (es) * 1987-09-18 1993-08-02 Hideaki Yamada Procedimiento para la produccion biologica de amidas
DE3821875C1 (no) * 1988-06-29 1990-02-15 Eprova Ag, Forschungsinstitut, Schaffhausen, Ch
CH681303A5 (no) * 1991-01-16 1993-02-26 Eprova Ag
CH684270A5 (de) * 1991-10-04 1994-08-15 Sapec Fine Chemicals Verfahren zur Herstellung von Erdalkalimetallsalzen von (6R)-N(10)-Formyl-5,6,7,8-tetrahydrofolsäure.
CH686672A5 (de) * 1992-12-01 1996-05-31 Cerbios Pharma Sa Verfahren zur Herstellung von (6S)-5,6,7,8-Tetrahydrofolsaeure.
GEP20012441B (en) * 1993-04-02 2001-05-25 Lonza Ag Process for Preparing 3-Methylpiperidine and 3-Methylpyridine
CH686369A5 (de) * 1994-05-09 1996-03-15 Eprova Ag Stabile kristalline (6S)- und (6R)-Tetrahydrofolseure.
CZ338596A3 (en) * 1994-05-23 1997-07-16 Lonza Ag Catalytic mixture for oxidative amonolysis of alkyl pyridines, process of its preparation and use

Also Published As

Publication number Publication date
HU9603072D0 (en) 1996-12-30
EP0773221A1 (de) 1997-05-14
CA2187409C (en) 2000-08-22
KR100296162B1 (ko) 2001-09-10
ZA969284B (en) 1997-05-07
KR100702201B1 (ko) 2007-11-12
US5817659A (en) 1998-10-06
ATE191482T1 (de) 2000-04-15
HUP9603072A3 (en) 1998-01-28
JP3382103B2 (ja) 2003-03-04
AU7053396A (en) 1997-05-15
AU707443B2 (en) 1999-07-08
CN1153176A (zh) 1997-07-02
JPH09169759A (ja) 1997-06-30
GR3033727T3 (en) 2000-10-31
HUP9603072A2 (en) 1997-08-28
KR970027056A (ko) 1997-06-24
CH689831A5 (de) 1999-12-15
CN1067392C (zh) 2001-06-20
EP0773221B1 (de) 2000-04-05
KR970027048A (ko) 1997-06-24
DE59604878D1 (de) 2000-05-11
RU2187508C2 (ru) 2002-08-20
ES2145360T3 (es) 2000-07-01
CA2187409A1 (en) 1997-05-08
TW533214B (en) 2003-05-21
DK0773221T3 (da) 2000-07-10
NO964699L (no) 1997-05-09
PT773221E (pt) 2000-09-29

Similar Documents

Publication Publication Date Title
NO964699D0 (no) Stabile, krystallinske tetrahydrofolsyresalter og fremgangsmåter for fremstilling av slike
NO20001886L (no) Stabile, krystallinske salter av 5-metyltetrahydrofolsyre og fremgangsmÕte til fremstilling derav
RU2000109346A (ru) Стабильная кристаллическая соль 5-метилтетрагидрофолиевой кислоты
ES2118283T3 (es) Derivados de acidos benzofuranil- y -tiofenil-alcanocarboxilicos.
RU96121625A (ru) Стабильная кристаллическая соль тетрагидрофолиевой кислоты
NO962321D0 (no) Nye krystallformer av vannfritt 7-([1,5,6Å-6-amino-3-azabicyklo [3.1.0Å heks-3-yl)-6-fluoro-1-2,4-difluorfenyl)-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre-metansulfonsyresalt
KR950032192A (ko) 안정한 결정성의 (6s)- 및 (6r)-테트라히드로폴산
KR840007878A (ko) 벤조퀴놀리진 카르복실산 유도체의 제조방법
FI881040A (fi) Foerfarande foer framstaellning av kristallisk cefadroxil-monohydrat.
FI881582A0 (fi) Foerfarande foer framstaellning av 3h-1,2,3-triazolo (4,5-d) pyrimidiner.
NO933367D0 (no) Sterkt vannloeselige, stablie, krystallinske salter av 2',3'-dideoksyinosin, 2',3'-dideoksy-2',3'didehydrotymidin og2',3'dideoksy-2'-fluorisin, og fremgangsmaate til fremstilling derav
YU53694A (sh) Kristali antimikrobnog jedinjenja
ATE137236T1 (de) Verfahren zur herstellung von pyrido(1,2- a>pyrimidinderivaten
ATE156824T1 (de) Verfahren zur herstellung von pyrido(1,2- a>pyrimidinderivaten
TH19997EX (th) ผลึกของสารประกอบต่อต้านการเจริญของจุลินทรีย์
HUT57779A (en) Process for producing new thiazetoquinoline-3-carboxylic acid derivatives
KR830009115A (ko) 세파드록신 모노하이드레이트의 제조방법

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application